New Zealand markets closed

Serina Therapeutics, Inc. (SER)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
8.14-0.66 (-7.50%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Total revenue
0
500
3,039
Operating expenses
Research development
1,567
1,573
3,799
Selling general and administrative
1,821
1,289
1,298
Total operating expenses
3,259
2,770
4,671
Operating income or loss
-3,259
-2,270
-1,632
Interest expense
297.581
15.878
3.094
Total other income/expenses net
4,662
-397.619
359.04
Income before tax
1,194
-2,682
-1,265
Income from continuing operations
1,194
-2,682
-1,265
Net income
1,194
-2,682
-1,265
Net income available to common shareholders
1,194
-2,682
-1,265
Basic EPS
0.48
-1.07
-0.51
Diluted EPS
0.48
-1.07
-0.51
Basic average shares
2,501
2,501
2,501
Diluted average shares
2,501
2,501
2,501